Authors:
Kamaluddin, M
McNally, P
Breatnach, F
O'Marcaigh, A
Webb, D
O'Dell, E
Scanlon, P
Butler, K
O'Meara, A
Citation: M. Kamaluddin et al., Potentiation of vincristine toxicity by itraconazole in children with lymphoid malignancies, ACT PAEDIAT, 90(10), 2001, pp. 1204-1207
Citation: Cs. Gudmundsson et P. Scanlon, Oral anticoagulation in acute coronary syndromes, EVIDENCE-BASED MANAGEMENT OF THE ACUTE CORONARY SYNDROME, 2001, pp. 167-179
Authors:
Griffin, ME
Coffey, M
Johnson, H
Scanlon, P
Foley, M
Stronge, J
O'Meara, NM
Firth, RG
Citation: Me. Griffin et al., Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome, DIABET MED, 17(1), 2000, pp. 26-32
Authors:
Dehmer, GJ
Arani, D
Noto, T
Scanlon, P
Hildner, F
Clark, D
Sheldon, W
Citation: Gj. Dehmer et al., Lessons learned from the review of cardiac catheterization laboratories: Areport from the Laboratory Survey Committee of the Society for Cardiac Angiography and Interventions, CATHET C IN, 46(1), 1999, pp. 24-31
Authors:
Messmore, HL
Kundur, R
Wehrmacher, W
Scanlon, P
Citation: Hl. Messmore et al., Anticoagulant therapy of pregnant patients with prosthetic heart valves: Rationale for a clinical trial of low molecular weight heparin, CL APPL T-H, 5(2), 1999, pp. 73-77
Authors:
Fonseca, S
Forsyth, H
Grigor, J
Lowe, J
MacKinnon, M
Price, E
Rose, S
Scanlon, P
Umapathy, D
Citation: S. Fonseca et al., Identification of permanent hearing loss in children: are the targets for outcome measures attainable?, BR J AUDIOL, 33(3), 1999, pp. 135-143